News
Tidepool announced that it began rolling out its new cloud-to-cloud integration with the Abbott (NYSE:ABT) FreeStyle Libre ...
Beta Bionics (Nasdaq:BBNX) shares rose after hours today on raised 2025 guidance and second-quarter results that beat the ...
Stelo, the first FDA-cleared over-the-counter glucose biosensor, joins the G7 continuous glucose monitor (CGM) in offering ...
Trinity Biotech (Nasdaq:TRIB) announced today that it unveiled its new flagship continuous glucose monitor (CGM) biosensor ...
Medtronic (NYSE:MDT) announced today that it received CE mark to expand its MiniMed 780G's indications, including for type 2 ...
Additionally, Tandem intends to release a software update aimed at enhancing the early detection of speaker failure. The ...
This notice comes just weeks after an initial warning about potential underinfusion with all Novum IQ large-volume pumps.
Abbott (NYSE:ABT) today reported Street-beating second-quarter results that included significant growth in its Diabetes ...
Stevanato Group today announced that it secured $235.5 million (€200 million) in financing to support ongoing capital ...
Dexcom (Nasdaq:DXCM) has issued an update related to a recall for its continuous glucose monitor (CGM) components.
BD (NYSE:BDX) today announced the first pharma-sponsored combination product clinical trial using its wearable injector ...
(NYSE:JNJ) announced today that the FDA granted priority review to a new drug application (NDA) for its TAR-200.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results